Research-Grade Anesthetic Gel Overview
Lox Jelly 2% is a topical lidocaine anesthetic formulation manufactured by Neon Laboratories Ltd. This gel-based preparation contains 2% lidocaine hydrochloride as the active ingredient, providing researchers with a standardized anesthetic compound for investigating local numbing mechanisms. The gel formulation enables controlled application and sustained contact time with target tissues in experimental protocols. Researchers at Stroid UK Shop utilize this preparation to examine topical anesthetic absorption, duration of action, and comparative efficacy studies against other local anesthetic compounds.
Laboratory Research Applications
This lidocaine gel preparation serves multiple research applications in anesthetic pharmacology studies. Scientists investigate the compound’s mechanism of sodium channel blockade in nerve tissue preparations, examining onset time and duration of local anesthetic effects. The gel matrix allows researchers to study sustained-release characteristics and tissue penetration properties compared to aqueous lidocaine solutions. Studies within the anesthetic drugs category frequently employ this formulation to evaluate topical delivery systems and bioavailability parameters. Research protocols examine the compound’s stability under various storage conditions, pH sensitivity, and interaction with other topical pharmaceutical agents.
Technical Specifications
| Active Ingredient | Lidocaine Hydrochloride 2% |
|---|---|
| Manufacturer | Neon Laboratories Ltd. |
| Formulation | Topical gel preparation |
| Storage Requirements | Room temperature, protect from light |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
Researchers comparing anesthetic compounds often examine this preparation alongside other research chemicals available through specialized suppliers, including advanced peptide formulations from the peptides collection and selective research modulators from the SARMs category.
Research Compliance Notice
Lox Jelly 2% is supplied exclusively for in-vitro laboratory research applications. This anesthetic gel is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must handle this compound according to institutional safety protocols and maintain proper documentation of experimental procedures. All studies utilizing this preparation should comply with relevant research ethics guidelines and laboratory safety standards for topical anesthetic compounds.
